This inventor holds 3 USPTO granted patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 2004-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,857 
1 out of 330 
Years Active: 2004-2011
Title: Gisela Peraus: Innovator in Gamma-Secretase Research
Introduction
Gisela Peraus is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the study of gamma-secretase, a crucial enzyme involved in various cellular processes. With a total of 3 patents, her work has implications for understanding and potentially treating diseases such as Alzheimer's.
Latest Patents
One of her latest patents is titled "Method of screening for gamma-secretase activity." This invention relates to an improved process for determining gamma-secretase activity and for detecting gamma-secretase, a subunit protein of gamma-secretase, or a gamma-secretase-like proteinase. The patent outlines processes for identifying gamma-secretase or cDNA that codes for it, as well as substances that can inhibit its activity. Another significant patent is the "Aβ-Peptide screening assay," which details a novel process for determining gamma-secretase activity and detecting the enzyme itself. This invention also focuses on identifying substances that can inhibit gamma-secretase activity, which is particularly important for developing pharmaceutical compounds for Alzheimer's treatment.
Career Highlights
Gisela has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. Her experience in these organizations has allowed her to collaborate on various innovative projects that advance the understanding of gamma-secretase and its role in human health.
Collaborations
Throughout her career, Gisela has collaborated with esteemed colleagues such as Edmund Hoppe and Ralf Baumeister. These partnerships have contributed to her research and the successful development of her patents.
Conclusion
Gisela Peraus is a pioneering inventor whose work on gamma-secretase has the potential to impact the treatment of Alzheimer's disease significantly. Her patents reflect her dedication to advancing scientific knowledge and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile